BioHarvest Sciences Inc. (BHST) Q3 2024 Earnings
BHST·Reported November 25, 2024·After market close
BioHarvest Sciences Inc. reported Q3 2024 revenue of $6.5M, missed analyst consensus of $7.2M by $699.0K. Diluted EPS came in at $-0.16, missed the $-0.05 consensus by $0.11.
Revenue
$6.5Mmissed by $699.0K
Consensus: $7.2MDiluted EPS
$-0.16missed by $0.11
Consensus: $-0.05
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q3 2024 Earnings FAQ
Common questions about BioHarvest Sciences Inc.'s Q3 2024 earnings report.
BioHarvest Sciences Inc. (BHST) reported Q3 2024 earnings on November 25, 2024 after market close.
BioHarvest Sciences Inc. reported revenue of $6.5M and diluted EPS of $-0.16 for Q3 2024.
Revenue missed the consensus estimate of $7.2M by $699.0K. EPS missed the consensus estimate of $-0.05 by $0.11.